LLY

738.06

+1.61%↑

JNJ

178.12

-0.03%↓

ABBV

209.99

-1.09%↓

UNH

320.2

+1.63%↑

NVO

54.31

-1.47%↓

LLY

738.06

+1.61%↑

JNJ

178.12

-0.03%↓

ABBV

209.99

-1.09%↓

UNH

320.2

+1.63%↑

NVO

54.31

-1.47%↓

LLY

738.06

+1.61%↑

JNJ

178.12

-0.03%↓

ABBV

209.99

-1.09%↓

UNH

320.2

+1.63%↑

NVO

54.31

-1.47%↓

LLY

738.06

+1.61%↑

JNJ

178.12

-0.03%↓

ABBV

209.99

-1.09%↓

UNH

320.2

+1.63%↑

NVO

54.31

-1.47%↓

LLY

738.06

+1.61%↑

JNJ

178.12

-0.03%↓

ABBV

209.99

-1.09%↓

UNH

320.2

+1.63%↑

NVO

54.31

-1.47%↓

Search

Medtronic PLC

Closed

SectorHealthcare

93.67 1.93

Overview

Share price change

24h

Current

Min

91.76

Max

92.96

Key metrics

By Trading Economics

Income

-17M

1B

Sales

-349M

8.6B

P/E

Sector Avg

25.638

35.733

EPS

1.26

Dividend yield

3.06

Profit margin

12.124

Employees

95,000

EBITDA

-50M

2.2B

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+7.1% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

3.06%

3.13%

Next Earnings

18 Nov 2025

Next Dividend date

17 Oct 2025

Next Ex Dividend date

26 Sept 2025

Market Stats

By TradingEconomics

Market Cap

133M

119B

Previous open

91.74

Previous close

93.67

News Sentiment

By Acuity

26%

74%

82 / 371 Healthcare

Technical Score

By Trading Central

Confidence

Weak Bearish Evidence

Medtronic PLC Chart

Past performance is not a reliable indicator of future results.

Related News

19 Aug 2025, 11:39 UTC

Earnings

Medtronic Posts Higher 1Q Revenue, Boosts Outlook as Tariffs Ease

21 May 2025, 11:38 UTC

Earnings
Acquisitions, Mergers, Takeovers

Medtronic Boosts Dividend, Plans to Separate Diabetes Business and Targets Revenue Growth for Year

19 Aug 2025, 20:33 UTC

Earnings
Acquisitions, Mergers, Takeovers

These Stocks Moved the Most Today: Intel, Home Depot, Palo Alto, Viking Therapeutics, Palantir, Medtronic, and More -- Barrons.com

19 Aug 2025, 17:41 UTC

Earnings
Acquisitions, Mergers, Takeovers

Medtronic Posts Earnings Beat and Elliott Buys Stake. The Stock Falls Anyway. -- Barrons.com

19 Aug 2025, 13:35 UTC

Hot Stocks

Stocks to Watch Tuesday: Intel, Medtronic, Home Depot -- WSJ

19 Aug 2025, 12:48 UTC

Earnings
Acquisitions, Mergers, Takeovers

Medtronic Posts Earnings Beat and Elliott Buys Stake. The Stock Falls Anyway. -- Barrons.com

19 Aug 2025, 11:27 UTC

Earnings

Medtronic Posts Earnings Beat and Elliott Buys Stake. The Stock Falls Anyway. -- Barrons.com

19 Aug 2025, 10:51 UTC

Earnings

Medtronic Sees FY26 Reported Revenue Growth 6.5%-6.8% >MDT

19 Aug 2025, 10:50 UTC

Earnings

Medtronic Had Seen FY26 Adjusted EPS $5.50-$5.60 >MDT

19 Aug 2025, 10:50 UTC

Earnings

Medtronic Raises FY26 View To Adj EPS $5.60-Adj EPS $5.66 >MDT

19 Aug 2025, 10:50 UTC

Earnings

Medtronic Cuts FY26 Potential Tariff Impact View to About $185M From $200M-$350M >MDT

19 Aug 2025, 10:49 UTC

Earnings

Medtronic Raises FY26 Adjusted EPS Growth View to About 4.5% From About 4%, Excluding Potential Tariff Impact >MDT

19 Aug 2025, 10:48 UTC

Earnings

Medtronic Still Sees FY26 Organic Revenue Up About 5% >MDT

19 Aug 2025, 10:45 UTC

Earnings

Medtronic 1Q Medical Surgical Portfolio Rev $2.08B >MDT

19 Aug 2025, 10:45 UTC

Earnings

Medtronic 1Q Cardiovascular Portfolio Rev $3.29B >MDT

19 Aug 2025, 10:45 UTC

Earnings

Medtronic 1Q Neuroscience Portfolio Rev $2.42B >MDT

19 Aug 2025, 10:45 UTC

Earnings

Medtronic 1Q Organic Revenue Up 4.8% >MDT

19 Aug 2025, 10:45 UTC

Earnings

Medtronic 1Q EPS 81c >MDT

19 Aug 2025, 10:45 UTC

Earnings

Medtronic 1Q Net $1.04B >MDT

19 Aug 2025, 10:45 UTC

Earnings

Medtronic 1Q Diabetes Rev $721M >MDT

19 Aug 2025, 10:45 UTC

Earnings

Medtronic 1Q Sales $8.58B >MDT

19 Aug 2025, 10:45 UTC

Earnings

Medtronic 1Q Adj EPS $1.26 >MDT

19 Aug 2025, 09:12 UTC

Hot Stocks

Stocks to Watch Tuesday: Intel, Palo Alto, Tegna, Home Depot -- WSJ

12 Jun 2025, 13:01 UTC

Acquisitions, Mergers, Takeovers

Medtronic Targeting Completion of Planned Separation Within 18 Mos of Initial Announcement >MDT

21 May 2025, 17:23 UTC

Top News
Acquisitions, Mergers, Takeovers

Medtronic to Separate Diabetes Business as Stand-Alone Company -- 2nd Update

21 May 2025, 11:39 UTC

Top News
Acquisitions, Mergers, Takeovers

Medtronic to Separate Diabetes Business as Stand-Alone Company -- Update

21 May 2025, 10:52 UTC

Earnings

Medtronic Sees FY26 Adjusted EPS Up About 4% Excluding Potential Impacts From Increased Tariffs >MDT

21 May 2025, 10:51 UTC

Earnings

Medtronic Sees FY26 Adj EPS $5.50-Adj EPS $5.60, Including Potential Tariff Impact >MDT

21 May 2025, 10:50 UTC

Earnings

Medtronic Sees FY26 Reported Revenue Up 4.8%-5.1% if Recent Forex Rates Hold >MDT

21 May 2025, 10:49 UTC

Earnings

Medtronic Sees FY26 Organic Revenue Growth Up About 5% >MDT

Peer Comparison

Price change

Medtronic PLC Forecast

Price Target

By TipRanks

7.1% upside

12 Months Forecast

Average 99.5 USD  7.1%

High 115 USD

Low 78 USD

Based on 25 Wall Street analysts offering 12 month price targets forMedtronic PLC - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

25 ratings

12

Buy

12

Hold

1

Sell

Technical Score

By Trading Central

83.26 / 84.875Support & Resistance

Short Term

Weak Bearish Evidence

Intermediate Term

Bullish Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

82 / 371 Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Medtronic PLC

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists; and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat other non-exclusive diseases and conditions; and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems, and InPen, a smart insulin pen system. The company was founded in 1949 and is headquartered in Galway, Ireland.
help-icon Live chat